Edwards Lifesciences Corp·4

May 27, 7:28 PM ET

BOBO DONALD E JR 4

4 · Edwards Lifesciences Corp · Filed May 27, 2026

Research Summary

AI-generated summary of this filing

Updated

Edwards Lifesciences (EW) CVP Donald E. Bobo Jr Sells 23,145 Shares

What Happened

  • Donald E. Bobo Jr, CVP, Strategy & Corporate Development at Edwards Lifesciences (EW), sold 23,145 shares on 2026-05-27. The reported weighted average sale price was $86.42 per share, for total proceeds of $2,000,193. The transactions were executed in multiple trades at prices ranging from $86.27 to $86.57.

Key Details

  • Transaction type: Sale (open market/private sale designated "S" on Form 4)
  • Date of transaction and report: 2026-05-27 (filed same day)
  • Price: weighted average $86.42; trade prices ranged $86.27–$86.57 (see footnote)
  • Shares sold: 23,145; proceeds approximately $2,000,193 (USD)
  • Shares owned after transaction: Not specified in the provided filing
  • Footnotes/remarks: Filing notes multiple trades and provides weighted average; reporting person offers to supply full trade-by-trade detail on request. Form states it reflects changes in beneficial ownership only and does not identify other securities held.
  • No 10b5-1 plan, tax withholding, option exercise, or late filing indicated in this Form 4.

Context

  • This is a straightforward open-market sale. Sales by company insiders can be routine (diversification, tax planning, liquidity) and do not by themselves signal a change in the company's outlook. Retail investors should consider this alongside other insider activity, company fundamentals, and broader market factors.

Insider Transaction Report

Form 4
Period: 2026-05-27
BOBO DONALD E JR
CVP,Strategy/Corp Development
Transactions
  • Sale

    Common Stock

    [F1]
    2026-05-27$86.42/sh23,145$2,000,19398,611 total(indirect: By Trust)
Holdings
  • Common Stock

    22,798.253
  • Common Stock

    (indirect: By 401(k))
    30,969.576
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $86.27 to $86.57. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Signature
Linda J. Park, Attorney-in-Fact|2026-05-27

Documents

1 file
  • 4
    doc4.xmlPrimary